Semiannual Report — FY2026 H1
What Japan Medical Dynamic Marketing,INC. reported for the period from 2026-04-01 to 2026-09-30. Filed by 株式会社 日本エム・ディ・エム
Filed 2026-11-13View the original on EDINET
How much it says
35Thin
What moved here
8named for the first time
Its own wording
15terms
Which filing this is
32/ 32newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the current interim consolidated accounting period, revenue declined year on year, resulting in an operating loss, an ordinary loss, and an interim net loss attributable to owners of the parent. The filing also disclosed, as a subsequent event, that ODEV, the U.S. subsidiary, will implement cost-cutting measures, including workforce reductions, from 15 October 2026 (U.S. time).
Komori's summary of this document, not the document's own words.35Thin
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 33 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
61
Detailed
68
Detailed
48
Typical
62
Detailed
0
Almost nothing
0
Almost nothing
0
Almost nothing
0
Almost nothing
53
Typical
0
Almost nothing
73
Detailed
R&D spend5億円Money spent making new things.
Cash left over-13億円Cash from the business, less what went into equipment.
Spent on equipment7億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.